Rhythm Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 6.95 M | $389.10 M | 0.89% | 11.35% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 6.57 M | $367.86 M | -8.95% | 10.73% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 6.08 M | $340.61 M | 0.00% | 9.94% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 6.08 M | $340.60 M | -4.91% | 9.94% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 3.68 M | $206.03 M | 3.38% | 6.01% |
| VANGUARD GROUP INC | 02/11/2025 | 3.44 M | $192.72 M | -0.15% | 5.62% |
| NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 2.91 M | $162.90 M | 0.00% | 4.75% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 1.87 M | $104.67 M | -22.64% | 3.05% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.81 M | $101.45 M | -53.29% | 2.96% |
| FEDERATED HERMES, INC. | 02/13/2025 | 1.55 M | $86.75 M | -6.87% | 2.53% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 1.50 M | $83.97 M | 0.00% | 2.45% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.29 M | $72.27 M | -0.66% | 2.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.26 M | $70.32 M | -0.03% | 2.05% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 1.22 M | $68.31 M | 103.90% | 1.99% |
| ALKEON CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.17 M | $65.37 M | 0.00% | 1.91% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.16 M | $65.09 M | -5.32% | 1.90% |
| CHECKPOINT CAPITAL L.P. | 02/14/2025 | 727,982 | $40.75 M | 9.74% | 1.19% |
| MARSHALL WACE, LLP | 02/13/2025 | 692,803 | $38.78 M | 70.38% | 1.13% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 685,152 | $38.36 M | 24.45% | 1.12% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/14/2025 | 643,691 | $36.03 M | 4.73% | 1.05% |
| LOOMIS SAYLES & CO L P | 02/12/2025 | 618,485 | $34.62 M | -2.85% | 1.01% |
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 500,000 | $27.99 M | 0.00% | 0.82% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 440,250 | $24.65 M | 1.47% | 0.72% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 400,000 | $22.39 M | -8.24% | 0.65% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 400,000 | $22.39 M | 0.00% | 0.65% |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 397,428 | $22.25 M | 43.64% | 0.65% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 380,537 | $21.30 M | 7.70% | 0.62% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 375,349 | $21.01 M | 13.97% | 0.61% |
| CANDRIAM S.C.A. | 02/07/2025 | 332,392 | $18.61 M | -15.93% | 0.54% |
| INVESCO LTD. | 02/13/2025 | 302,846 | $16.95 M | 14.53% | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 273,896 | $15.33 M | 7.17% | 0.45% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 268,205 | $15.01 M | 3.39% | 0.44% |
| JPMORGAN CHASE & CO | 02/12/2025 | 264,585 | $14.81 M | 224.28% | 0.43% |
| UBS GROUP AG | 02/14/2025 | 254,264 | $14.23 M | 231.79% | 0.42% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 218,544 | $12.23 M | -3.03% | 0.36% |
| STEMPOINT CAPITAL LP | 02/14/2025 | 208,016 | $11.64 M | 404.06% | 0.34% |
| NORGES BANK | 02/12/2025 | 205,649 | $11.51 M | 100.00% | 0.34% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 172,647 | $9.66 M | 0.00% | 0.28% |
| LORD, ABBETT & CO. LLC | 02/14/2025 | 160,651 | $8.99 M | 56.51% | 0.26% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 150,000 | $8.40 M | 100.00% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 148,246 | $8.30 M | -0.46% | 0.24% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 146,903 | $8.22 M | -0.66% | 0.24% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 144,342 | $8.08 M | 100.00% | 0.24% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 138,363 | $7.75 M | 100.00% | 0.23% |
| BARCLAYS PLC | 02/13/2025 | 135,397 | $7.58 M | 27.26% | 0.22% |
| FIRST TRUST ADVISORS LP | 02/13/2025 | 118,337 | $6.62 M | 67.23% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 115,300 | $6.45 M | -50.43% | 0.19% |
| FMR LLC | 02/13/2025 | 113,109 | $6.33 M | 124.89% | 0.18% |
| LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 106,261 | $5.95 M | 100.00% | 0.17% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/15/2025 | 99,447 | $5.57 M | -1.50% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rhythm Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 227 institutional investors and hedge funds held shares of Rhythm Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 6.95 M
PRIMECAP MANAGEMENT CO/CA/: 6.57 M
RA CAPITAL MANAGEMENT, L.P.: 6.08 M
BAKER BROS. ADVISORS LP: 6.08 M
PERCEPTIVE ADVISORS LLC: 3.68 M
VANGUARD GROUP INC: 3.44 M
106.01% of Rhythm Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 69.71 M shares in the last 24 months. This purchase volume represents approximately $4.11 B in transactions.